BSE Live
Dec 31, 16:01Prev. Close
1387.65
Open Price
1373.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:56Prev. Close
1386.20
Open Price
1386.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1418.90 (252)
| Cash Flow of Ipca Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 784.97 | 557.39 | 282.80 | 258.20 | 111.45 | |
| Net CashFlow From Operating Activities | 554.35 | 495.65 | 323.86 | 271.14 | 696.00 | |
| Net Cash Used In Investing Activities | -498.13 | -122.98 | -119.34 | -145.55 | -213.62 | |
| Net Cash Used From Financing Activities | -132.59 | -222.83 | -130.43 | -156.39 | -414.16 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -76.37 | 149.84 | 74.09 | -30.80 | 68.22 | |
| Cash And Cash Equivalents Begin of Year | 348.44 | 198.60 | 124.51 | 155.31 | 87.09 | |
| Cash And Cash Equivalents End Of Year | 272.07 | 348.44 | 198.60 | 124.51 | 155.31 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher